CA2070685A1 - Methode de traitement des affections douloureuses, inflammatoires ou allergiques - Google Patents

Methode de traitement des affections douloureuses, inflammatoires ou allergiques

Info

Publication number
CA2070685A1
CA2070685A1 CA2070685A CA2070685A CA2070685A1 CA 2070685 A1 CA2070685 A1 CA 2070685A1 CA 2070685 A CA2070685 A CA 2070685A CA 2070685 A CA2070685 A CA 2070685A CA 2070685 A1 CA2070685 A1 CA 2070685A1
Authority
CA
Canada
Prior art keywords
inflammatory
allergic disorders
treating painful
painful
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2070685A
Other languages
English (en)
Other versions
CA2070685C (fr
Inventor
Joel E. Bernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cisco LP
Original Assignee
Joel E. Bernstein
Cisco Limited Partnership
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joel E. Bernstein, Cisco Limited Partnership filed Critical Joel E. Bernstein
Publication of CA2070685A1 publication Critical patent/CA2070685A1/fr
Application granted granted Critical
Publication of CA2070685C publication Critical patent/CA2070685C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002070685A 1989-12-19 1990-06-28 Methode de traitement des affections douloureuses, inflammatoires ou allergiques Expired - Lifetime CA2070685C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/452,476 US5063060A (en) 1989-12-19 1989-12-19 Compositions and method for treating painful, inflammatory or allergic disorders
US452,476 1989-12-19

Publications (2)

Publication Number Publication Date
CA2070685A1 true CA2070685A1 (fr) 1991-06-20
CA2070685C CA2070685C (fr) 1994-11-01

Family

ID=23796595

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070685A Expired - Lifetime CA2070685C (fr) 1989-12-19 1990-06-28 Methode de traitement des affections douloureuses, inflammatoires ou allergiques

Country Status (13)

Country Link
US (1) US5063060A (fr)
EP (1) EP0506658B1 (fr)
JP (1) JPH0780761B2 (fr)
KR (1) KR950015056B1 (fr)
AT (1) ATE138567T1 (fr)
AU (1) AU645023B2 (fr)
CA (1) CA2070685C (fr)
DE (1) DE69027220T2 (fr)
DK (1) DK0506658T3 (fr)
ES (1) ES2087160T3 (fr)
IL (1) IL95820A (fr)
RU (1) RU2095060C1 (fr)
WO (1) WO1991008738A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648113A4 (fr) * 1992-04-23 1996-12-04 Berlex Lab Emulsion d'huile minerale solide bioadhesive.
US6063381A (en) * 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US6635659B1 (en) * 1995-03-20 2003-10-21 Arrie Kegler Topical formulation for arthritic symptoms treatment
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US5840762A (en) * 1996-01-12 1998-11-24 Genderm Corporation Method for the treatment of cardiac arrhythmias and shortening of action potential duration
DE19622271A1 (de) * 1996-06-03 1997-12-04 Basf Ag Chirale Verbindungen
GB9711962D0 (en) 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
JP4677063B2 (ja) * 1997-07-18 2011-04-27 帝國製薬株式会社 オランダカラシエキス配合外用製剤
US6284797B1 (en) * 1999-04-12 2001-09-04 Donald A. Rhodes Topical treatment of pain and to promote healing
MXPA05006670A (es) * 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
JP2006514109A (ja) * 2002-12-18 2006-04-27 アルゴルクス ファーマスーティカルズ，インク カプサイシノイドの投与
US20040146464A1 (en) * 2003-01-23 2004-07-29 Bernstein Joel E. Compositions and method for daily tooth and gum care
US20050085552A1 (en) * 2003-10-16 2005-04-21 Winston Laboratories, Inc. Method for providing long-lasting pain relief through intrathecal administration of civamide
US7244446B2 (en) * 2003-10-16 2007-07-17 Winston Laboratories, Inc. Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide
CN100411538C (zh) * 2004-06-15 2008-08-20 味之素株式会社 含有辣椒苷的辣椒干燥物及其干燥方法
WO2007013690A1 (fr) * 2005-07-28 2007-02-01 Ajinomoto Co., Inc. Procédé permettant la préparation pour une application locale et supplément répondant aux besoins du client
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
US20110014269A1 (en) * 2009-07-14 2011-01-20 Winston Laboratories, Inc. Civamide patch for localized post-incisional neuropathic pain
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460602A (en) * 1981-06-30 1984-07-17 The Procter & Gamble Company Urea derivatives
US4546112A (en) * 1981-12-14 1985-10-08 The Procter & Gamble Company Method for preventing or reducing dipilatory irritation
US4536404A (en) * 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4702916A (en) * 1985-12-03 1987-10-27 Warner-Lambert Company Analgesic stick compositions

Also Published As

Publication number Publication date
IL95820A (en) 1996-08-04
KR920703041A (ko) 1992-12-17
EP0506658A4 (en) 1993-03-03
DE69027220T2 (de) 1997-01-02
JPH05504546A (ja) 1993-07-15
EP0506658B1 (fr) 1996-05-29
US5063060A (en) 1991-11-05
AU6064890A (en) 1991-07-18
JPH0780761B2 (ja) 1995-08-30
RU2095060C1 (ru) 1997-11-10
ATE138567T1 (de) 1996-06-15
AU645023B2 (en) 1994-01-06
DK0506658T3 (da) 1996-06-24
ES2087160T3 (es) 1996-07-16
KR950015056B1 (ko) 1995-12-21
WO1991008738A1 (fr) 1991-06-27
DE69027220D1 (de) 1996-07-04
CA2070685C (fr) 1994-11-01
EP0506658A1 (fr) 1992-10-07

Similar Documents

Publication Publication Date Title
CA2070685A1 (fr) Methode de traitement des affections douloureuses, inflammatoires ou allergiques
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
AU610036B2 (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis inflammation and as immunosuppressants
GR3019179T3 (en) Flupirtine in combination with antiparkinsonica against muscle bracing
EP0206529A3 (fr) Traitement de maladies orales
CA2254682A1 (fr) Methode de traitement d'infections oculaires au moyen d'azithromycine
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
EE04953B1 (et) Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
DE68917071T2 (de) Mittel zur stimulierung der tränensekretion.
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
HK1006278A1 (en) Novel compositions
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
IE870577L (en) Topical amide preparation
CA2192965A1 (fr) Compositions d'analogues d'anandamide et procede de traitement de l'hypertension intra-oculaire a l'aide de telles compositions
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
AU562828B2 (en) Morphine-vitamin b12 analgesic treatment
AU8069891A (en) Novel alpha-glucosidase inhibitors
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
HU9402863D0 (en) New cardioprotective agents
IL129267A0 (en) Treatment of urinary incontinence and compositions for use therein
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
GR3023250T3 (en) Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways
AU5448490A (en) Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202